Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Investment

Cytiva to build chromatography resin plant in the US

by Michael McCoy
July 23, 2022 | A version of this story appeared in Volume 100, Issue 26

Cytiva says it will spend $600 million to build its first chromatography resin plant outside Sweden. The company, owned by Danaher, has acquired a facility in Muskegon, Michigan, that it will retrofit to produce the resins, which are used to purify and analyze biomolecules. Cytiva will get support from the State of Michigan and from US agencies, including the Biomedical Advanced Research and Development Authority.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.